Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole in Pulmonary Arterial Hypertension
NCT01545336Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Oct 2012
- Primary completion
- Jun 2015
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anastrozole in pulmonary arterial hypertension (PAH), sponsored by University of Pennsylvania. Started Oct 2012; status: completed.
02
Drugs
anastrozole
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01545336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545336.